Devin Whittemore Smith - Net Worth and Insider Trading

Devin Whittemore Smith Net Worth

The estimated net worth of Devin Whittemore Smith is at least $59,077 dollars as of 2025-07-24. Devin Whittemore Smith is the General Counsel of IO Biotech Inc and owns about 16,938 shares of IO Biotech Inc (IOBT) stock worth over $32,690. Devin Whittemore Smith is also the SVP and General Counsel of Yumanity Therapeutics Inc and owns about 13,961 shares of Yumanity Therapeutics Inc (YMTX) stock worth over $26,386. Details can be seen in Devin Whittemore Smith's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Devin Whittemore Smith has not made any transactions after 2024-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Devin Whittemore Smith

To

Devin Whittemore Smith Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Devin Whittemore Smith owns 4 companies in total, including Minerva Neurosciences Inc (NERV) , Yumanity Therapeutics Inc (YMTX) , and IO Biotech Inc (IOBT) among others .

Click here to see the complete history of Devin Whittemore Smith’s form 4 insider trades.

Insider Ownership Summary of Devin Whittemore Smith

Ticker Company Transaction Date Type of Owner
NERV Minerva Neurosciences Inc 2018-07-23 SVP and General Counsel
YMTX Yumanity Therapeutics Inc 2022-12-02 SVP and General Counsel
IOBT IO Biotech Inc 2024-12-23 General Counsel
LIMIT LIMIT 2021-06-14 SVP and General Counsel

Devin Whittemore Smith Latest Holdings Summary

Devin Whittemore Smith currently owns a total of 2 stocks. Among these stocks, Devin Whittemore Smith owns 16,938 shares of IO Biotech Inc (IOBT) as of December 23, 2024, with a value of $32,690 and a weighting of 55.34%. Devin Whittemore Smith also owns 13,961 shares of Yumanity Therapeutics Inc (YMTX) as of December 2, 2022, with a value of $26,386 and a weighting of 44.66%.

Latest Holdings of Devin Whittemore Smith

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IOBT IO Biotech Inc 2024-12-23 16,938 1.93 32,690
YMTX Yumanity Therapeutics Inc 2022-12-02 13,961 1.89 26,386

Holding Weightings of Devin Whittemore Smith


Devin Whittemore Smith Form 4 Trading Tracker

According to the SEC Form 4 filings, Devin Whittemore Smith has made a total of 1 transactions in IO Biotech Inc (IOBT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in IO Biotech Inc is the acquisition of 12,000 shares on December 23, 2024, which cost Devin Whittemore Smith around $9,720.

According to the SEC Form 4 filings, Devin Whittemore Smith has made a total of 2 transactions in Yumanity Therapeutics Inc (YMTX) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Yumanity Therapeutics Inc is the sale of 3,116 shares on December 2, 2022, which brought Devin Whittemore Smith around $5,266.

Insider Trading History of Devin Whittemore Smith

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Devin Whittemore Smith Trading Performance

GuruFocus tracks the stock performance after each of Devin Whittemore Smith's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Devin Whittemore Smith is 7.9%. GuruFocus also compares Devin Whittemore Smith's trading performance to market benchmark return within the same time period. The performance of stocks bought by Devin Whittemore Smith within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Devin Whittemore Smith's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Devin Whittemore Smith

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 0.61 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -1.81 LIMIT LIMIT LIMIT LIMIT LIMIT

Devin Whittemore Smith Ownership Network

Ownership Network List of Devin Whittemore Smith

No Data

Ownership Network Relation of Devin Whittemore Smith

Insider Network Chart


Devin Whittemore Smith Owned Company Details

What does Minerva Neurosciences Inc do?

Who are the key executives at Minerva Neurosciences Inc?

Devin Whittemore Smith is the SVP and General Counsel of Minerva Neurosciences Inc. Other key executives at Minerva Neurosciences Inc include 10 percent owner Ag Boehringer , 10 percent owner Boehringer Ingelheim International Gmbh , and EVP and Head of R&D Remy Luthringer .

Minerva Neurosciences Inc (NERV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Minerva Neurosciences Inc (NERV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Minerva Neurosciences Inc (NERV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Minerva Neurosciences Inc (NERV)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Minerva Neurosciences Inc Insider Transactions

No Available Data

Devin Whittemore Smith Mailing Address

Above is the net worth, insider trading, and ownership report for Devin Whittemore Smith. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Devin Whittemore Smith's mailing address is: Waltham Ma 02451.